GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
37.95
+0.36 (0.96%)
At close: Mar 3, 2025, 4:00 PM
38.77
+0.82 (2.16%)
Pre-market: Mar 4, 2025, 7:15 AM EST
GSK Revenue
In the year 2024, GSK had annual revenue of 31.38B GBP with 3.46% growth. GSK had revenue of 8.12B in the quarter ending December 31, 2024, with 0.81% growth.
Revenue (ttm)
31.38B GBP
Revenue Growth
+3.46%
P/S Ratio
1.95
Revenue / Employee
457,183 GBP
Employees
68,629
Market Cap
76.69B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
GSK News
- 4 days ago - GSK abandons diversity targets following Trump pressure - Reuters
- 12 days ago - Canada purchases 500,000 doses of GSK's vaccine for bird flu - Reuters
- 14 days ago - GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy' - Seeking Alpha
- 14 days ago - Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors - Benzinga
- 15 days ago - PENMENVY, GSK's 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY - Business Wire
- 17 days ago - US FDA approves GSK's combo meningococcal vaccine - Reuters
- 17 days ago - Hedge Fund Citadel takes short position in GSK, FT reports - Reuters
- 18 days ago - India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs - Reuters